InvestSMART

The Hydration Pharmaceuticals Company Limited (ASX:HPC)

ALERT: Price-sensitive ASX Announcement for HPC
Current share price for HPC : $0.004 0 (0%)+
Release
1 May 2026 9:21AM
Price at Release
$0.004
Full Release
download
Summary
On May 1, 2026, the securities of The Hydration Pharmaceuticals Company Limited (HPC) were suspended from quotation on the ASX under Listing Rule 17.5. This suspension was due to the company's failure to lodge the required periodic report by the specified due date. The announcement indicates that if the report is filed after the market announcements office closure on April 30, 2026, and before the suspension, the securities would typically be reinstated on the next trading day following the suspension.
Key Points
  • Suspension from quotation under Listing Rule 17.5
  • Failure to lodge the relevant periodic report by the due date
  • Potential reinstatement upon report submission after market closure but before suspension
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.